Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.42
Percentage change -1.42	%

Peers: AMRX ANIP ARDX ASRT ASND EYPT HRTX LXRX PCRX PTGX

| Held by: IJR VTI IWM VXF CALF IJT SPSM IWO PJP PBE

Index	RUT	P/E	24.05	EPS (ttm)	1.21	Insider Own	4.18%	Shs Outstand	32.13M	Perf Week	-3.38%
Market Cap	937.91M	Forward P/E	4.16	EPS next Y	7.01	Insider Trans	-12.20%	Shs Float	30.79M	Perf Month	0.38%
Income	43.89M	PEG	-	EPS next Q	1.65	Inst Own	116.14%	Short Float	15.93%	Perf Quarter	-0.95%
Sales	664.28M	P/S	1.41	EPS this Y	6.63%	Inst Trans	-1.72%	Short Ratio	13.58	Perf Half Y	-3.22%
Book/sh	7.30	P/B	4.00	EPS next Y	1.93%	ROA	3.20%	Short Interest	4.90M	Perf Year	-10.41%
Cash/sh	6.77	P/C	4.31	EPS next 5Y	-0.71%	ROE	19.23%	52W Range	23.23 - 42.29	Perf YTD	1.85%
Dividend Est.	-	P/FCF	4.77	EPS past 5Y	-	ROIC	3.87%	52W High	-31.00%	Beta	0.65
Dividend TTM	-	Quick Ratio	1.01	Sales past 5Y	16.31%	Gross Margin	57.69%	52W Low	25.61%	ATR (14)	0.80
Dividend Ex-Date	-	Current Ratio	1.08	EPS Y/Y TTM	-51.97%	Oper. Margin	24.90%	RSI (14)	49.44	Volatility	0.97% 1.49%
Employees	357	Debt/Eq	4.12	Sales Y/Y TTM	17.17%	Profit Margin	6.61%	Recom	1.40	Target Price	43.00
Option/Short	Yes / Yes	LT Debt/Eq	3.84	EPS Q/Q	-89.60%	Payout	0.00%	Rel Volume	0.63	Prev Close	29.60
Sales Surprise	3.38%	EPS Surprise	4.01%	Sales Q/Q	22.66%	Earnings	May 08 AMC	Avg Volume	361.12K	Price	29.18
SMA20	-1.22%	SMA50	3.38%	SMA200	-7.77%	Trades		Volume	227,489	Change	-1.42%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-10-25	Upgrade	Needham	Hold → Buy	$46
Jul-30-24	Upgrade	H.C. Wainwright	Neutral → Buy	$47
Jun-07-24	Upgrade	Jefferies	Hold → Buy	$41 → $44
May-10-24	Downgrade	Piper Sandler	Overweight → Neutral	$39
May-10-24	Downgrade	Needham	Buy → Hold
Jan-04-24	Downgrade	Jefferies	Buy → Hold	$30 → $37
Aug-25-23	Reiterated	Needham	Buy	$35 → $36
May-02-23	Resumed	Jefferies	Buy	$30
Aug-08-22	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-15-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$18 → $26
Aug-06-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-11-21	Reiterated	H.C. Wainwright	Buy	$29 → $33
Jul-14-20	Initiated	BWS Financial	Sell	$8
May-27-20	Initiated	Guggenheim	Neutral
Feb-19-20	Resumed	Jefferies	Buy	$43
Oct-30-19	Reiterated	Needham	Buy	$33 → $25
May-03-19	Resumed	H.C. Wainwright	Buy	$23
Apr-12-19	Resumed	Janney	Buy	$29
Mar-20-19	Initiated	SunTrust	Hold	$22
Jan-16-19	Reiterated	Needham	Buy	$35 → $33

Show Previous Ratings

Jun-10-25 04:40AM	COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities (StockStory)
Jun-05-25 11:31PM	Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers (StockStory)
May-19-25 04:01PM	Collegium to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-25 08:05AM	Collegium Announces $25 Million Accelerated Share Repurchase Program (GlobeNewswire)
May-09-25 03:42AM	Collegium Pharmaceutical Inc (COLL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) +5.94%
05:30PM	Loading…
May-08-25 05:30PM	Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates (Zacks)
04:11PM	Collegium Pharmaceutical: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
May-07-25 06:15PM	ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
05:20PM	Collegium Pharmaceutical Q1 2025 Earnings Preview (Seeking Alpha)
10:28AM	Collegium Pharmaceutical Inc (COLL) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
May-01-25 10:01AM	Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-28-25 12:12PM	Indivior: Trying To Break Addiction (Seeking Alpha)
09:01AM	3 Healthcare Stocks That Concern Us (StockStory)
08:00AM	Loading…
Apr-24-25 08:00AM	Collegium to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
03:55AM	Third Avenue Small Cap Value Fund Q1 2025 Commentary (Seeking Alpha)
Apr-23-25 09:40AM	Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? (Zacks)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
Apr-14-25 05:11AM	2 Reasons to Watch COLL and 1 to Stay Cautious (StockStory)
Apr-02-25 05:05AM	A Look Back at Branded Pharmaceuticals Stocks' Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack (StockStory)
Apr-01-25 08:00AM	Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-25 08:00AM	Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting (GlobeNewswire)
Mar-26-25 07:00AM	Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board (GlobeNewswire)
Mar-18-25 03:22PM	Teva Pharmaceutical Stock Scores RS Rating Upgrade (Investor's Business Daily)
Mar-17-25 07:00AM	Collegium Announces Updates to its Board of Directors and Executive Leadership Team (GlobeNewswire)
Mar-10-25 06:57PM	Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care (GlobeNewswire)
Mar-04-25 08:00AM	Collegium to Participate in Upcoming Investor Conferences (GlobeNewswire)
Mar-01-25 06:45AM	Is Collegium Pharmaceutical, Inc. (COLL) the Best Small Cap Pharma Stocks to Buy Now? (Insider Monkey)
Feb-28-25 07:05AM	Q4 2024 Collegium Pharmaceutical Inc Earnings Call (Thomson Reuters StreetEvents)
02:37AM	Loading…
02:37AM	Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Feb-27-25 07:00PM	Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:45PM	Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:52PM	Collegium Pharmaceutical: Q4 Earnings Snapshot (Associated Press Finance)
04:28PM	Collegium Pharmaceuticals (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1% (StockStory)
04:01PM	Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results (GlobeNewswire)
Feb-26-25 09:15AM	Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:12AM	Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect (StockStory)
07:53AM	What To Expect From Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 08:00AM	Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Feb-05-25 08:00AM	Collegium Appoints Nancy S. Lurker to its Board of Directors (GlobeNewswire)
Jan-09-25 08:30AM	Collegium Pharmaceutical Unveils 2025 Financial Projections (TipRanks)
Jan-08-25 08:00AM	Collegium Provides 2025 Financial Guidance and Business Update (GlobeNewswire) +14.41%
Nov-13-24 09:40AM	Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? (Zacks)
Nov-12-24 08:00AM	Collegium to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 10:03AM	Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) -7.35%
08:34AM	Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? (Zacks)
Nov-07-24 06:30PM	Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings (Zacks)
05:35PM	Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates (Zacks)
04:34PM	Collegium Pharmaceutical: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Collegium Reports Record Third Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Collegium Appoints Vikram Karnani as Chief Executive Officer (GlobeNewswire)
Nov-06-24 07:25AM	What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings (GuruFocus.com)
Oct-31-24 10:01AM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-28-24 09:40AM	Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? (Zacks)
Oct-24-24 08:00AM	Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-11-24 09:40AM	Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? (Zacks)
Oct-09-24 05:55PM	Collegium Pharmaceutical Inc (COLL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Oct-04-24 02:37PM	Breakouts Boost These Three Stocks To All-Time Highs (Investor's Business Daily)
Sep-25-24 09:40AM	Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? (Zacks)
Sep-09-24 12:00PM	Collegium Pharmaceutical (COLL) Upgraded to Buy: Here's Why (Zacks)
09:40AM	Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? (Zacks)
Sep-07-24 01:28AM	Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ... (GuruFocus.com)
Sep-04-24 08:00AM	Collegium Completes Acquisition of Ironshore Therapeutics (GlobeNewswire)
Aug-30-24 08:00AM	Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-28-24 08:00AM	Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024 (GlobeNewswire)
Aug-08-24 09:59PM	COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
06:00PM	Collegium Pharmaceutical (COLL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:20PM	Collegium Pharmaceutical: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Collegium Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-07-24 09:15AM	Unveiling Collegium Pharmaceutical (COLL) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Aug-01-24 10:01AM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy? (Zacks)
06:30AM	Compass Pathways announces second quarter 2024 financial results and business highlights (GlobeNewswire)
Jul-31-24 06:53AM	Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock? (Zacks)
Jul-30-24 09:33AM	Collegium buys Ironshore for $525m and enter ADHD market (Pharmaceutical Technology) +10.63%
Jul-29-24 06:00AM	Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology (GlobeNewswire)
Jul-25-24 08:00AM	Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
Jun-24-24 12:56PM	7 Biotech Stocks to Buy on the Dip: June 2024 (InvestorPlace)
Jun-13-24 08:00AM	Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise (GlobeNewswire)
Jun-10-24 05:16PM	Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Upgraded by Jefferies (Insider Monkey)
Jun-09-24 01:07AM	Street calls of the week: Upgrades for Best Buy and Lululemon (Investing.com)
Jun-06-24 02:32AM	Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 25,000 Shares of Collegium ... (GuruFocus.com)
May-30-24 02:40AM	Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL) (GuruFocus.com)
May-29-24 08:00AM	Collegium to Participate in Jefferies Global Healthcare Conference (GlobeNewswire)
May-13-24 09:31AM	Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program (MT Newswires)
08:00AM	Collegium Announces $35 Million Accelerated Share Repurchase Program (GlobeNewswire)
May-10-24 02:01PM	Collegium Pharmaceutical Reports First Quarter 2024 Earnings (GuruFocus.com) -16.80%
12:17PM	Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024 (Associated Press Finance)
09:51AM	--Needham Downgrades Collegium Pharmaceutical to Hold From Buy (MT Newswires)
04:48AM	Collegium Pharmaceutical Q1 Adjusted Net Income, Revenue Rise; 2024 Outlook Reiterated (MT Newswires)
May-09-24 06:00PM	Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:40PM	Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates (Zacks)
04:36PM	Collegium Pharmaceutical: Q1 Earnings Snapshot (Associated Press Finance)
04:02PM	Collegium Reports First Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Collegium Announces CEO Transition (GlobeNewswire)
May-07-24 09:15AM	Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-02-24 10:01AM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-29-24 09:45AM	Collegium (COLL) to Report Q1 Earnings: Here's What to Expect (Zacks)
08:00AM	Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta and Nucynta ER (GlobeNewswire)

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Freund John Gordon	Director	Jun 09 '25	Option Exercise	13.45	15,000	201,750	77,259	Jun 11 05:04 PM
Freund John Gordon	Director	Jun 09 '25	Sale	30.62	6,601	202,149	70,658	Jun 11 05:04 PM
Freund John Gordon	Director	Jun 09 '25	Proposed Sale	30.62	6,601	202,148		Jun 09 01:02 PM
Tupper Colleen	EVP & Chief Financial Officer	Mar 21 '25	Sale	30.03	6,396	192,069	156,667	Mar 24 05:06 PM
Tupper Colleen	EVP & Chief Financial Officer	Mar 20 '25	Sale	30.00	1,206	36,181	163,063	Mar 24 05:06 PM
Dreyer Scott	EVP & Chief Commercial Officer	Mar 21 '25	Sale	30.03	18,881	566,983	103,613	Mar 24 05:05 PM
Dreyer Scott	EVP & Chief Commercial Officer	Mar 20 '25	Sale	30.00	1,927	57,811	122,494	Mar 24 05:05 PM
Tupper Colleen	Officer	Mar 21 '25	Proposed Sale	30.03	6,396	192,069		Mar 21 04:35 PM
Dreyer Scott	Officer	Mar 21 '25	Proposed Sale	30.03	18,881	566,984		Mar 21 04:21 PM
Tupper Colleen	Officer	Mar 20 '25	Proposed Sale	30.00	1,206	36,181		Mar 20 04:32 PM
Kuhlmann Shirley R.	Former Officer	Mar 20 '25	Proposed Sale	29.65	40,494	1,200,632		Mar 20 04:19 PM
Dreyer Scott	Officer	Mar 20 '25	Proposed Sale	30.00	1,927	57,811		Mar 20 04:17 PM
Tupper Colleen	EVP & Chief Financial Officer	Mar 14 '25	Sale	30.00	977	29,313	164,269	Mar 18 05:35 PM
Dreyer Scott	EVP & Chief Commercial Officer	Mar 14 '25	Sale	30.00	2,255	67,661	124,421	Mar 18 05:34 PM
Tupper Colleen	Officer	Mar 14 '25	Proposed Sale	30.00	977	29,313		Mar 14 04:06 PM
Dreyer Scott	Officer	Mar 14 '25	Proposed Sale	30.00	2,255	67,661		Mar 14 03:55 PM
Dreyer Scott	EVP & Chief Commercial Officer	Mar 06 '25	Sale	30.00	15,387	461,672	126,676	Mar 13 04:50 PM
Tupper Colleen	EVP & Chief Financial Officer	Mar 11 '25	Sale	30.01	10,445	313,413	165,246	Mar 13 04:49 PM
Tupper Colleen	Officer	Mar 11 '25	Proposed Sale	30.01	10,445	313,413		Mar 11 04:16 PM
Dreyer Scott	Officer	Mar 11 '25	Proposed Sale	30.00	15,387	461,672		Mar 11 04:08 PM
Tupper Colleen	EVP & Chief Financial Officer	Mar 06 '25	Sale	30.00	1,949	58,470	177,195	Mar 10 04:02 PM
Tupper Colleen	EVP & Chief Financial Officer	Mar 07 '25	Sale	30.00	1,504	45,121	175,691	Mar 10 04:02 PM
Dreyer Scott	EVP & Chief Commercial Officer	Mar 06 '25	Sale	30.00	3,295	98,854	144,411	Mar 10 04:01 PM
Dreyer Scott	EVP & Chief Commercial Officer	Mar 07 '25	Sale	30.00	2,348	70,446	142,063	Mar 10 04:01 PM
Dreyer Scott	Officer	Mar 07 '25	Proposed Sale	30.00	2,348	70,446		Mar 07 04:21 PM
Tupper Colleen	Officer	Mar 07 '25	Proposed Sale	30.00	1,504	45,121		Mar 07 04:13 PM
Kuhlmann Shirley R.	EVP and General Counsel	Mar 04 '25	Option Exercise	24.03	40,000	961,200	194,204	Mar 06 06:48 PM
Kuhlmann Shirley R.	EVP and General Counsel	Mar 04 '25	Sale	28.08	40,000	1,123,160	154,204	Mar 06 06:48 PM
Kuhlmann Shirley R.	EVP and General Counsel	Mar 06 '25	Sale	28.50	26,067	742,946	108,137	Mar 06 06:48 PM
Kuhlmann Shirley R.	EVP and General Counsel	Mar 05 '25	Sale	28.03	20,000	560,528	134,204	Mar 06 06:48 PM
Tupper Colleen	Officer	Mar 06 '25	Proposed Sale	30.00	1,949	58,470		Mar 06 04:43 PM
Dreyer Scott	Officer	Mar 06 '25	Proposed Sale	30.00	3,295	98,854		Mar 06 04:31 PM
Kuhlmann Shirley R.	Officer	Mar 06 '25	Proposed Sale	28.50	26,067	742,946		Mar 06 10:42 AM
Kuhlmann Shirley R.	Officer	Mar 05 '25	Proposed Sale	28.03	20,000	560,528		Mar 05 03:03 PM
Kuhlmann Shirley R.	Officer	Mar 04 '25	Proposed Sale	28.08	40,000	1,123,160		Mar 04 04:16 PM
Kuhlmann Shirley R.	EVP and General Counsel	Jan 10 '25	Option Exercise	21.34	27,500	586,850	146,684	Jan 14 04:12 PM
Kuhlmann Shirley R.	EVP and General Counsel	Jan 10 '25	Sale	33.04	27,500	908,628	119,184	Jan 14 04:12 PM
Kuhlmann Shirley R.	Officer	Jan 10 '25	Proposed Sale	33.04	27,500	908,628		Jan 10 04:14 PM
Smith Thomas B	EVP and Chief Medical Officer	Sep 13 '24	Sale	36.62	9,593	351,320	53,816	Sep 17 04:32 PM
Smith Thomas B	Officer	Sep 13 '24	Proposed Sale	36.98	373	13,794		Sep 13 10:39 AM
Smith Thomas B	Officer	Sep 13 '24	Proposed Sale	36.61	9,220	337,516		Sep 13 10:06 AM
Kuhlmann Shirley R.	EVP and General Counsel	Sep 05 '24	Sale	38.30	19,248	737,198	120,161	Sep 06 05:52 PM
Kuhlmann Shirley R.	EVP and General Counsel	Sep 06 '24	Sale	37.46	977	36,594	119,184	Sep 06 05:52 PM
Kuhlmann Shirley R.	Officer	Sep 06 '24	Proposed Sale	37.46	977	36,594		Sep 06 11:53 AM
Kuhlmann Shirley R.	Officer	Sep 05 '24	Proposed Sale	38.30	19,248	737,197		Sep 05 04:47 PM
McFarlane Neil F.	Former Director	Aug 12 '24	Proposed Sale	35.21	44,365	1,562,312		Aug 12 02:41 PM
McFarlane Neil F.	Former Director	Aug 09 '24	Proposed Sale	35.20	5,000	176,007		Aug 09 04:34 PM

Open in Screener

SIBN

SI-BONE Inc

Jun 13 • 04:00PM ET

17.42

Dollar change -0.84
Percentage change -4.60	%

Healthcare • Medical Devices • USA • NASD

Peers: GMED ATEC OFIX MDT SYK ZBH JNJ IART BAX BVS

| Held by: IWM VTI VXF IWO IHI SCHA VTWO VHT IWC XHE

Index	RUT	P/E	-	EPS (ttm)	-0.64	Insider Own	13.46%	Shs Outstand	42.48M	Perf Week	-7.83%
Market Cap	742.34M	Forward P/E	-	EPS next Y	-0.44	Insider Trans	-3.46%	Shs Float	36.88M	Perf Month	-7.09%
Income	-26.55M	PEG	-	EPS next Q	-0.18	Inst Own	87.36%	Short Float	5.04%	Perf Quarter	18.10%
Sales	176.60M	P/S	4.20	EPS this Y	15.56%	Inst Trans	1.62%	Short Ratio	4.12	Perf Half Y	22.68%
Book/sh	3.94	P/B	4.42	EPS next Y	30.00%	ROA	-11.77%	Short Interest	1.86M	Perf Year	32.57%
Cash/sh	3.39	P/C	5.14	EPS next 5Y	21.46%	ROE	-15.96%	52W Range	11.70 - 20.05	Perf YTD	24.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	13.67%	ROIC	-13.06%	52W High	-13.12%	Beta	0.95
Dividend TTM	-	Quick Ratio	7.26	Sales past 5Y	19.96%	Gross Margin	79.25%	52W Low	48.89%	ATR (14)	0.65
Dividend Ex-Date	-	Current Ratio	8.53	EPS Y/Y TTM	41.26%	Oper. Margin	-17.38%	RSI (14)	42.86	Volatility	2.53% 2.35%
Employees	349	Debt/Eq	0.22	Sales Y/Y TTM	22.60%	Profit Margin	-15.04%	Recom	1.00	Target Price	24.67
Option/Short	Yes / Yes	LT Debt/Eq	0.22	EPS Q/Q	42.00%	Payout	-	Rel Volume	3.71	Prev Close	18.26
Sales Surprise	4.78%	EPS Surprise	33.54%	Sales Q/Q	24.88%	Earnings	May 05 AMC	Avg Volume	450.24K	Price	17.42
SMA20	-7.46%	SMA50	5.71%	SMA200	14.24%	Trades		Volume	1,592,410	Change	-4.60%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-24	Reiterated	Needham	Buy	$27 → $19
Mar-28-24	Initiated	Piper Sandler	Overweight	$25
Oct-12-22	Initiated	Jefferies	Buy	$20
Apr-07-22	Resumed	Cantor Fitzgerald	Overweight	$34
Jun-08-21	Initiated	Citigroup	Buy	$40
Mar-09-21	Reiterated	Needham	Buy	$35 → $34
Dec-16-20	Reiterated	Needham	Buy	$28 → $35
Aug-04-20	Reiterated	Needham	Buy	$22 → $24
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight	$25
May-05-20	Reiterated	Needham	Buy	$27 → $22
Feb-19-20	Initiated	Needham	Buy	$27
Jan-08-20	Initiated	SunTrust	Buy	$27
Dec-18-19	Initiated	Cantor Fitzgerald	Overweight	$27
Nov-12-18	Initiated	Morgan Stanley	Overweight	$24
Nov-12-18	Initiated	JMP Securities	Mkt Outperform	$27
Nov-12-18	Initiated	Canaccord Genuity	Buy	$25
Nov-12-18	Initiated	BofA/Merrill	Buy	$23

Show Previous Ratings

Jun-04-25 04:30PM	SI-BONE to Truist Securities MedTech Conference on June 17, 2025 (GlobeNewswire)
04:30PM	SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025 (GlobeNewswire)
May-28-25 04:30PM	SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025 (GlobeNewswire)
May-26-25 09:55AM	Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? (Zacks)
May-14-25 07:30AM	4 Recent Earnings Winners Riding Fresh Momentum in May (MarketBeat)
12:00PM	Loading…
May-13-25 12:00PM	What Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now? (Zacks)
May-08-25 09:55AM	Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet (Zacks)
May-06-25 04:09PM	SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025 (GlobeNewswire) +15.44% +6.20%
08:35AM	Q1 2025 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents)
03:05AM	SI-BONE Inc (SIBN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... (GuruFocus.com)
May-05-25 05:20PM	Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:27PM	Si-Bone: Q1 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance (GlobeNewswire)
May-02-25 09:29AM	SI-BONE Inc (SIBN) Q1 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Apr-14-25 04:09PM	SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025 (GlobeNewswire)
10:42AM	Loading…
Apr-10-25 10:42AM	IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last? (Zacks)
Apr-08-25 07:00PM	SI-BONE, Inc.: Small-cap Developer Of Medical Implants And A Steady Revenue Grower (Seeking Alpha) +6.58%
Feb-26-25 10:01AM	SI-Bone price target raised to $24 from $20 at Needham (TipRanks)
Feb-25-25 09:03AM	Q4 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents) +5.55%
02:03AM	SI-BONE Inc (SIBN) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Positive EBITDA (GuruFocus.com)
Feb-24-25 05:40PM	Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:43PM	Si-Bone: Q4 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance (GlobeNewswire)
Feb-22-25 04:21PM	SI-BONE Inc (SIBN) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-21-25 08:00AM	Bruker Appoints Laura Francis to its Board of Directors (Business Wire)
Feb-17-25 10:00AM	Si-Bone (SIBN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-03-25 04:09PM	SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025 (GlobeNewswire) +5.29%
Jan-18-25 08:00AM	SI-Bone price target raised to $20 from $19 at Needham (TipRanks)
Jan-13-25 09:00AM	SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 (GlobeNewswire) +18.29%
Dec-12-24 09:55AM	Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.71%: Here's is How to Trade (Zacks)
09:55AM	Loading…
Nov-26-24 09:55AM	Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? (Zacks)
Nov-20-24 04:09PM	SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 (GlobeNewswire)
Nov-13-24 10:54AM	Q3 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents) -15.93%
02:18AM	SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Revenue and Path to Profitability (GuruFocus.com)
Nov-12-24 05:25PM	Si-Bone (SIBN) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:21PM	Si-Bone: Q3 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance (GlobeNewswire)
Nov-11-24 07:13AM	SI-BONE Inc (SIBN) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-05-24 08:30AM	SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite (GlobeNewswire) +6.75%
Oct-30-24 03:35AM	Strength Seen in Si-Bone (SIBN): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Oct-22-24 04:09PM	SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024 (GlobeNewswire)
Oct-14-24 07:28AM	First patients are treated with Si-Bones pelvic fracture fixation device (Medical Device Network)
Oct-10-24 08:30AM	SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation (GlobeNewswire)
Aug-26-24 09:55AM	Wall Street Analysts Think Si-Bone (SIBN) Could Surge 40.3%: Read This Before Placing a Bet (Zacks)
08:19AM	SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System (Zacks)
Aug-22-24 04:30PM	SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024 (GlobeNewswire) +11.07%
Aug-20-24 08:30AM	SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System (GlobeNewswire)
Aug-08-24 09:55AM	Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.45%: Here's is How to Trade (Zacks)
Aug-06-24 09:16AM	Q2 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents)
08:30AM	SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024 (GlobeNewswire)
Aug-05-24 05:55PM	Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:55PM	Si-Bone: Q2 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024 (GlobeNewswire)
Jul-15-24 04:09PM	SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024 (GlobeNewswire) +8.92%
Jun-05-24 04:09PM	SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024 (GlobeNewswire)
May-07-24 11:16AM	SI-BONE, Inc. (NASDAQ:SIBN) Q1 2024 Earnings Call Transcript (Insider Monkey) +8.29%
09:00AM	SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures (GlobeNewswire)
08:04AM	Q1 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents)
03:08AM	SI-BONE Inc (SIBN) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-06-24 05:25PM	Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:24PM	Si-Bone: Q1 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the First Quarter 2024 (GlobeNewswire)
Apr-29-24 10:00AM	Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
09:00AM	SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024 (GlobeNewswire)
Apr-15-24 04:09PM	SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024 (GlobeNewswire)
Mar-04-24 04:09PM	SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024 (GlobeNewswire)
Feb-27-24 06:49AM	Q4 2023 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents) -13.53%
Feb-26-24 05:38PM	Si-Bone: Q4 Earnings Snapshot (Associated Press Finance)
04:34PM	SI-BONE Inc (SIBN) Reports Record Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:09PM	SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance (GlobeNewswire)
Feb-19-24 10:00AM	Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-05-24 04:09PM	SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024 (GlobeNewswire)
Jan-30-24 08:30AM	SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application (GlobeNewswire)
Jan-22-24 10:54AM	15 Small-Cap Stocks with High Potential (Insider Monkey)
Jan-08-24 08:30AM	SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 (GlobeNewswire) -7.06%
Jan-05-24 09:02AM	SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares (GuruFocus.com)
Nov-30-23 09:30AM	Si-Bone (SIBN) Crossed Above the 50-Day Moving Average: What That Means for Investors (Zacks)
Nov-21-23 07:03AM	Insider Sell: President, Commercial Ops Anthony Recupero Sells 8,457 Shares of SI-BONE Inc (SIBN) (GuruFocus.com)
Nov-14-23 04:09PM	SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023 (GlobeNewswire) +9.47%
Nov-07-23 11:08AM	SI-BONE, Inc. (NASDAQ:SIBN) Q3 2023 Earnings Call Transcript (Insider Monkey)
10:00AM	Q3 2023 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 05:38PM	Si-Bone: Q3 Earnings Snapshot (Associated Press Finance)
05:01PM	SI-BONE Inc (SIBN) Reports Record Q3 2023 Financial Results, Raises Annual Guidance (GuruFocus.com)
04:09PM	SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance (GlobeNewswire)
Nov-01-23 04:09PM	SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023 (GlobeNewswire)
Oct-16-23 04:09PM	SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023 (GlobeNewswire)
Oct-09-23 12:00PM	Si-Bone (SIBN) Upgraded to Buy: Here's Why (Zacks)
Sep-08-23 09:40AM	Has SiBone (SIBN) Outpaced Other Medical Stocks This Year? (Zacks)
Sep-06-23 09:55AM	Does Si-Bone (SIBN) Have the Potential to Rally 39.93% as Wall Street Analysts Expect? (Zacks)
Sep-05-23 04:09PM	SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods (GlobeNewswire)
Aug-29-23 04:09PM	SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023 (GlobeNewswire)
Aug-09-23 10:07AM	SI-BONE, Inc. (NASDAQ:SIBN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 06:23AM	Q2 2023 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents) -11.17%
Aug-07-23 05:20PM	Si-Bone: Q2 Earnings Snapshot (AP Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance (GlobeNewswire)
Jul-19-23 04:09PM	SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023 (GlobeNewswire)
Jul-17-23 04:09PM	SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire)
Jul-06-23 10:00AM	Best Momentum Stocks to Buy for July 6th (Zacks)
May-29-23 10:15AM	Despite shrinking by US$86m in the past week, SI-BONE (NASDAQ:SIBN) shareholders are still up 69% over 1 year (Simply Wall St.)
May-24-23 04:09PM	SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023 (GlobeNewswire)

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DUNN JEFFREY W	Director	Jun 05 '25	Sale	19.05	3,377	64,335	17,354	Jun 06 07:48 PM
FRANCIS LAURA	Chief Executive Officer	May 16 '25	Sale	19.67	12,385	243,670	495,170	May 20 07:48 PM
FRANCIS LAURA	Chief Executive Officer	May 19 '25	Sale	19.49	5,412	105,464	490,987	May 20 07:48 PM
Maheshwari Anshul	Chief Financial Officer	May 16 '25	Sale	19.76	9,585	189,399	224,507	May 20 07:47 PM
Maheshwari Anshul	Chief Financial Officer	May 19 '25	Sale	19.48	2,424	47,213	222,083	May 20 07:47 PM
RECUPERO ANTHONY J	President, Commercial Ops	May 16 '25	Sale	19.56	4,147	81,109	282,015	May 20 07:46 PM
Pisetsky Michael A	SVP, Ops & Adm/Chief Legal Ofr	May 16 '25	Sale	19.66	3,459	68,006	264,636	May 20 07:45 PM
DAVID & LAURA FRANCIS JOINT RE	Director	May 19 '25	Proposed Sale	19.79	5,412	107,103		May 19 04:57 PM
ANSHUL MAHESHWARI	Officer	May 19 '25	Proposed Sale	19.79	2,424	47,971		May 19 04:57 PM
ANSHUL MAHESHWARI	Officer	May 16 '25	Proposed Sale	18.88	4,958	93,607		May 16 04:21 PM
Maheshwari Anshul	Chief Financial Officer	May 12 '25	Sale	19.02	4,937	93,926	232,069	May 14 08:33 PM
ANSHUL MAHESHWARI	Officer	May 12 '25	Proposed Sale	18.49	4,937	91,285		May 12 04:27 PM
FRANCIS LAURA	Chief Executive Officer	May 07 '25	Sale	17.18	38,504	661,368	302,958	May 09 07:01 PM
Maheshwari Anshul	Chief Financial Officer	May 08 '25	Sale	18.17	28,350	515,094	237,006	May 09 07:00 PM
Maheshwari Anshul	Chief Financial Officer	May 07 '25	Sale	17.00	4,937	83,939	265,356	May 09 07:00 PM
ANSHUL MAHESHWARI	Officer	May 08 '25	Proposed Sale	17.47	28,350	495,274		May 08 04:23 PM
ANSHUL MAHESHWARI	Officer	May 07 '25	Proposed Sale	16.45	4,937	81,214		May 07 04:21 PM
DAVID & LAURA FRANCIS JOINT RE	Officer	May 07 '25	Proposed Sale	16.45	38,504	633,391		May 07 04:21 PM
DUNN JEFFREY W	Director	May 01 '25	Sale	13.78	336	4,628	12,536	May 02 05:08 PM
Pisetsky Michael A	SVP, Ops & Adm/Chief Legal Ofr	Apr 30 '25	Option Exercise	4.68	21,367	99,998	266,245	May 02 05:07 PM
Pisetsky Michael A	SVP, Ops & Adm/Chief Legal Ofr	Apr 02 '25	Sale	14.14	3,128	44,219	244,878	Apr 04 05:14 PM
RECUPERO ANTHONY J	President, Commercial Ops	Apr 02 '25	Sale	14.15	3,311	46,853	284,555	Apr 04 05:13 PM
Maheshwari Anshul	Chief Financial Officer	Apr 02 '25	Sale	14.11	3,311	46,723	270,293	Apr 04 05:12 PM
FRANCIS LAURA	Chief Executive Officer	Feb 18 '25	Sale	17.22	46,233	795,915	506,761	Feb 21 04:19 PM
Maheshwari Anshul	Chief Financial Officer	Feb 18 '25	Sale	16.86	11,180	188,518	273,604	Feb 21 04:18 PM
RECUPERO ANTHONY J	President, Commercial Ops	Feb 18 '25	Sale	16.86	9,531	160,732	287,866	Feb 21 04:17 PM
DUNN JEFFREY W	Director	Feb 18 '25	Sale	16.77	1,619	27,152	15,191	Feb 21 04:16 PM
DUNN JEFFREY W	Director	Feb 03 '25	Sale	16.51	337	5,562	17,290	Feb 05 06:09 PM
RECUPERO ANTHONY J	President, Commercial Ops	Jan 02 '25	Sale	13.90	3,670	51,014	222,814	Jan 06 06:58 PM
Maheshwari Anshul	Chief Financial Officer	Jan 02 '25	Sale	13.91	5,304	73,802	189,319	Jan 06 06:56 PM
DUNN JEFFREY W	Director	Nov 18 '24	Sale	12.43	1,609	20,001	20,431	Nov 20 05:13 PM
RECUPERO ANTHONY J	President, Commercial Ops	Nov 18 '24	Sale	12.60	3,937	49,609	228,554	Nov 20 05:12 PM
RECUPERO ANTHONY J	President, Commercial Ops	Nov 19 '24	Sale	12.17	2,070	25,195	226,484	Nov 20 05:12 PM
Maheshwari Anshul	Chief Financial Officer	Nov 18 '24	Sale	12.68	2,439	30,937	194,623	Nov 20 05:11 PM
FRANCIS LAURA	Chief Executive Officer	Nov 18 '24	Sale	12.58	10,048	126,354	482,875	Nov 20 05:10 PM
ANTHONY JOHN RECUPERO	Officer	Nov 19 '24	Proposed Sale	12.36	2,070	25,585		Nov 19 04:24 PM
DUNN JEFFREY W	Director	Nov 04 '24	Sale	13.55	341	4,621	22,040	Nov 06 06:19 PM
RECUPERO ANTHONY J	President, Commercial Ops	Oct 02 '24	Sale	13.58	3,305	44,877	233,412	Oct 04 06:55 PM
RECUPERO ANTHONY J	President, Commercial Ops	Oct 03 '24	Sale	13.60	921	12,526	232,491	Oct 04 06:55 PM
Maheshwari Anshul	Chief Financial Officer	Oct 02 '24	Sale	13.58	3,305	44,886	197,062	Oct 04 06:54 PM
ANTHONY JOHN RECUPERO	Officer	Oct 03 '24	Proposed Sale	13.60	921	12,526		Oct 03 04:28 PM
Maheshwari Anshul	Chief Financial Officer	Sep 03 '24	Sale	16.35	1,414	23,119	200,367	Sep 04 05:51 PM
ANSHUL MAHESHWARI	Officer	Sep 03 '24	Proposed Sale	16.62	1,414	23,501		Sep 03 04:21 PM
RECUPERO ANTHONY J	President, Commercial Ops	Aug 16 '24	Sale	13.84	3,905	54,037	238,804	Aug 20 07:54 PM
RECUPERO ANTHONY J	President, Commercial Ops	Aug 19 '24	Sale	14.17	2,087	29,569	236,717	Aug 20 07:54 PM
Maheshwari Anshul	Chief Financial Officer	Aug 16 '24	Sale	13.87	2,418	33,538	198,762	Aug 20 07:53 PM
FRANCIS LAURA	Chief Executive Officer	Aug 16 '24	Sale	13.84	9,967	137,970	492,923	Aug 20 07:52 PM
DUNN JEFFREY W	Director	Aug 16 '24	Sale	13.84	1,580	21,867	25,212	Aug 20 07:51 PM
ANTHONY JOHN RECUPERO	Officer	Aug 19 '24	Proposed Sale	13.87	2,087	28,947		Aug 19 04:27 PM
DUNN JEFFREY W	Director	Aug 02 '24	Sale	14.32	343	4,912	26,792	Aug 06 05:38 PM
RECUPERO ANTHONY J	President, Commercial Ops	Jul 02 '24	Sale	12.92	3,309	42,755	243,629	Jul 05 05:48 PM
RECUPERO ANTHONY J	President, Commercial Ops	Jul 03 '24	Sale	13.05	920	12,007	242,709	Jul 05 05:48 PM
Maheshwari Anshul	Chief Financial Officer	Jul 02 '24	Sale	12.90	3,309	42,694	201,180	Jul 05 05:41 PM

COLL

Collegium Pharmaceutical Inc

SIBN

SI-BONE Inc

Upgrade your FINVIZ experience